Watch Demo

Global Synthetic Biology Industry

Global Synthetic Biology Industry

  • Publish Date:January 2023

  • Number of Pages:442

  • Report ID:1375238

  • Format:PDF

  • Publisher:Global Industry Analysts

$ 5450

Summary

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Synthetic Biology Market to Reach $77.5 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Synthetic Biology estimated at US$10.8 Billion in the year 2022, is projected to reach a revised size of US$77.5 Billion by 2030, growing at a CAGR of 27.9% over the analysis period 2022-2030. Oligonucleotides & Synthetic DNA, one of the segments analyzed in the report, is projected to record a 29.1% CAGR and reach US$35.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Enzymes segment is readjusted to a revised 26.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.3 Billion, While China is Forecast to Grow at 32.5% CAGR

The Synthetic Biology market in the U.S. is estimated at US$4.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$8.9 Billion by the year 2030 trailing a CAGR of 32.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 26.2% and 27.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 29.2% CAGR.

Select Competitors (Total 141 Featured)
- Agilent Technologies, Inc
- Amyris, Inc
- Arzeda
- Atum
- Codexis, Inc
- Creative Enzymes
- Cyrus Biotechnology, Inc
- Editas Medicine, Inc
- Eurofins Genomics Blue Heron LLC
- Eurofins Scientific
- GENEWIZ, Inc
- GeneWorks Pty Ltd
- Genscript Biotech Corporation
- Ginkgo Bioworks
- Integrated Dna Technologies, Inc
- New England Biolabs
- Novozymes A/S
- OriGene Technologies, Inc
- Sanofi S.A.
- Synthego Corporation
- TeselaGen Biotechnology Inc
- Thermo Fisher Scientific, Inc
- Twist Bioscience

Table of contents

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
COVID-19 Pandemic Poised to Drive Demand for Synthetic Biology
Synthetic Biologists Create Slow-Growing Version of COVID-19 as
Vaccine Candidate
Role of Synthetic Biology in Combating COVID-19
2020 Marked as a Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Where is
the World Economy Headed in 2021
World Economic Growth Projections (Real GDP, Annual % Change)
for 2020 through 2022
Synthetic Biology - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Synthetic Biology - A New Interdisciplinary Field
Growing Importance of Synthetic Biology
Applications of Synthetic Biology
Synthetic Biology Tools
Technologies Involved
Market Outlook
Regional Landscape
Major Challenges and Concerns
Teaming R&D Funding & Potential to Alter Molecular Landscape
Enable Global Synthetic Biology Market to Remain in High
Spirits
Synthetic Biology to Radically Change the World for Good with
Endless Applications
Competitive Landscape
Major Players by Industry Verticals
Select Market Participants
Synthetic Biology Startups Get Aggressive on Bioengineered
Product Commercialization
Compelling Breakthroughs Drive Funding
Top Funded Synthetic Biology Startups in Q2 2020
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Synthetic Biology Market Witnesses Significant Rise in Investments
Importance of Synthetic Biology for Investments
Efforts from Leading Players Bodes Well for Market Growth
Patent Landscape Gets Richer
Synthetic Biology Patent Landscape by Assignee Countries (in %)
: 2003-2020
Top 15 Patent Assignees in Synthetic Biology Domain: 2003-2018
Select Patent Assignees for Synthetic Biology in the US: 2019
Robotics and Workflow Automation Support Market Expansion
Advancements in Instrumentation Augurs Well
Improvements in Computer-Aided Biology
Fusion of AI and Synthetic Biology Expands Opportunities
Synthetic Biology Brings a Paradigm Shift in the Field of
Biological Research
DNA Sequencing Plays an Important Role
Plummeting Cost of DNA Sequencing Bolsters Market Growth
Cost per Genome Sequencing: 2001-2020
Food Scarcity to Fuel Synthetic Biology Application in Agriculture
Select Companies Engaged in Making Food Using Synthetic Biology
Synthetic Biology Aids in Development of Exotic and
Artificially Grown Meats and Proteins to Meet Future Food
Demand
Growing Demand for GM Crops Opens Up Growth Avenues
Synthetic Biology-based Ingredients Gain Traction
Role of Synthetic Biology in Producing Plants with Desirable
Characteristics
Synthetic Biology Gains Prominence in Biomedical Applications
Synthetic Genes Open up a New World of Drug Development
Synthetic Biology to Transform Healthcare with Captivating
Advances in Biomedicine
Synthetic Biology Enables Creation of Advanced Biosensing Systems
Synthetic Biology Gains Significance in Production of Bio-Based
Chemicals and Biofuels
Global Biofuels Market in US$ Billion: 2019 and 2024
Synthetic Biology Gains Importance as Focus on Carbon Recycling
Increases
Synthetic Biology Disrupts the Cosmetics Sector
Capability of Synthetic Biology in Environmental Applications
Synthetic Biology Creates Buzz as Key Enabler of Exciting &
Dynamic Applications for Diverse Domains
Synthetic Biology for Advanced, Multifunctional Materials
Genetically Engineered Fabrics and Sustainable Dyes Using
Synthetic Biology to Transform Textile Industry
Select Synthetic Biology Offerings in Textile Industry
Personalized Medicine to Display Notable Leap Forward with
Synthetic Biology
3D Bio-Printing

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Synthetic Biology by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Synthetic Biology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2021
and % CAGR

Table 3: World 15-Year Perspective for Synthetic Biology by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2015, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Oligonucleotides & Synthetic DNA by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Oligonucleotides & Synthetic
DNA by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2021
and % CAGR

Table 6: World 15-Year Perspective for Oligonucleotides &
Synthetic DNA by Geographic Region - Percentage Breakdown of
Value Revenues for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2015, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Enzymes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2022
through 2030 and % CAGR

Table 8: World Historic Review for Enzymes by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2015 through 2021 and % CAGR

Table 9: World 15-Year Perspective for Enzymes by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
for Years 2015, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Cloning Technology Kits by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Cloning Technology Kits by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2021
and % CAGR

Table 12: World 15-Year Perspective for Cloning Technology Kits
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Synthetic Cells by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Synthetic Cells by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2021
and % CAGR

Table 15: World 15-Year Perspective for Synthetic Cells by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Xeno-Nucleic Acids (XNA) by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Xeno-Nucleic Acids (XNA) by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2021
and % CAGR

Table 18: World 15-Year Perspective for Xeno-Nucleic Acids
(XNA) by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2015, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Chassis Organism by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Chassis Organism by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2021
and % CAGR

Table 21: World 15-Year Perspective for Chassis Organism by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Nucleotide Synthesis & Sequencing by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 23: World Historic Review for Nucleotide Synthesis &
Sequencing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2015
through 2021 and % CAGR

Table 24: World 15-Year Perspective for Nucleotide Synthesis &
Sequencing by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2015, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for
Genome Engineering by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2022 through 2030 and % CAGR

Table 26: World Historic Review for Genome Engineering by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2021
and % CAGR

Table 27: World 15-Year Perspective for Genome Engineering by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2023 & 2030

Table 28: World Recent Past, Current & Future Analysis for
Microfluidics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2022
through 2030 and % CAGR

Table 29: World Historic Review for Microfluidics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2015 through 2021 and % CAGR

Table 30: World 15-Year Perspective for Microfluidics by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2023 & 2030

Table 31: World Recent Past, Current & Future Analysis for
Other Technologies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2022 through 2030 and % CAGR

Table 32: World Historic Review for Other Technologies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2021
and % CAGR

Table 33: World 15-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2023 & 2030

Table 34: World Recent Past, Current & Future Analysis for
Pharmaceuticals & Diagnostics by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 35: World Historic Review for Pharmaceuticals &
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2015
through 2021 and % CAGR

Table 36: World 15-Year Perspective for Pharmaceuticals &
Diagnostics by Geographic Region - Percentage Breakdown of
Value Revenues for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2015, 2023 & 2030

Table 37: World Recent Past, Current & Future Analysis for
Industrial by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2022
through 2030 and % CAGR

Table 38: World Historic Review for Industrial by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2015 through 2021 and % CAGR

Table 39: World 15-Year Perspective for Industrial by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2023 & 2030

Table 40: World Recent Past, Current & Future Analysis for Food &
Agriculture by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2022
through 2030 and % CAGR

Table 41: World Historic Review for Food & Agriculture by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2021
and % CAGR

Table 42: World 15-Year Perspective for Food & Agriculture by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2023 & 2030

Table 43: World Recent Past, Current & Future Analysis for
Environmental by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2022
through 2030 and % CAGR

Table 44: World Historic Review for Environmental by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2015 through 2021 and % CAGR

Table 45: World 15-Year Perspective for Environmental by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2023 & 2030

Table 46: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2022 through 2030 and % CAGR

Table 47: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2021
and % CAGR

Table 48: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2023 & 2030

Table 49: World Synthetic Biology Market Analysis of Annual
Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

UNITED STATES
Synthetic Biology Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United States for 2023 (E)
Table 50: USA Recent Past, Current & Future Analysis for
Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA,
Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic
Acids (XNA) and Chassis Organism - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 51: USA Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2015 through 2021 and % CAGR

Table 52: USA 15-Year Perspective for Synthetic Biology by Tool -
Percentage Breakdown of Value Revenues for Oligonucleotides &
Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic
Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the
Years 2015, 2023 & 2030

Table 53: USA Recent Past, Current & Future Analysis for
Synthetic Biology by Technology - Nucleotide Synthesis &
Sequencing, Genome Engineering, Microfluidics and Other
Technologies - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 54: USA Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2021 and % CAGR

Table 55: USA 15-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Revenues for
Nucleotide Synthesis & Sequencing, Genome Engineering,
Microfluidics and Other Technologies for the Years 2015, 2023 &
2030

Table 56: USA Recent Past, Current & Future Analysis for
Synthetic Biology by Application - Pharmaceuticals &
Diagnostics, Industrial, Food & Agriculture, Environmental and
Other Applications - Independent Analysis of Annual Revenues in
US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 57: USA Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2021 and % CAGR

Table 58: USA 15-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Revenues for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2023 &
2030

CANADA
Table 59: Canada Recent Past, Current & Future Analysis for
Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA,
Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic
Acids (XNA) and Chassis Organism - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 60: Canada Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2015 through 2021 and % CAGR

Table 61: Canada 15-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Revenues for
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism for the Years 2015, 2023 & 2030

Table 62: Canada Recent Past, Current & Future Analysis for
Synthetic Biology by Technology - Nucleotide Synthesis &
Sequencing, Genome Engineering, Microfluidics and Other
Technologies - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 63: Canada Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2021 and % CAGR

Table 64: Canada 15-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Revenues for
Nucleotide Synthesis & Sequencing, Genome Engineering,
Microfluidics and Other Technologies for the Years 2015, 2023 &
2030

Table 65: Canada Recent Past, Current & Future Analysis for
Synthetic Biology by Application - Pharmaceuticals &
Diagnostics, Industrial, Food & Agriculture, Environmental and
Other Applications - Independent Analysis of Annual Revenues in
US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 66: Canada Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2021 and % CAGR

Table 67: Canada 15-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Revenues for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2023 &
2030

JAPAN
Synthetic Biology Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Japan for 2023 (E)
Table 68: Japan Recent Past, Current & Future Analysis for
Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA,
Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic
Acids (XNA) and Chassis Organism - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 69: Japan Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2015 through 2021 and % CAGR

Table 70: Japan 15-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Revenues for
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism for the Years 2015, 2023 & 2030

Table 71: Japan Recent Past, Current & Future Analysis for
Synthetic Biology by Technology - Nucleotide Synthesis &
Sequencing, Genome Engineering, Microfluidics and Other
Technologies - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 72: Japan Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2021 and % CAGR

Table 73: Japan 15-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Revenues for
Nucleotide Synthesis & Sequencing, Genome Engineering,
Microfluidics and Other Technologies for the Years 2015, 2023 &
2030

Table 74: Japan Recent Past, Current & Future Analysis for
Synthetic Biology by Application - Pharmaceuticals &
Diagnostics, Industrial, Food & Agriculture, Environmental and
Other Applications - Independent Analysis of Annual Revenues in
US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 75: Japan Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2021 and % CAGR

Table 76: Japan 15-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Revenues for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2023 &
2030

CHINA
Synthetic Biology Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in China for 2023 (E)
Table 77: China Recent Past, Current & Future Analysis for
Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA,
Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic
Acids (XNA) and Chassis Organism - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 78: China Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2015 through 2021 and % CAGR

Table 79: China 15-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Revenues for
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism for the Years 2015, 2023 & 2030

Table 80: China Recent Past, Current & Future Analysis for
Synthetic Biology by Technology - Nucleotide Synthesis &
Sequencing, Genome Engineering, Microfluidics and Other
Technologies - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 81: China Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2021 and % CAGR

Table 82: China 15-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Revenues for
Nucleotide Synthesis & Sequencing, Genome Engineering,
Microfluidics and Other Technologies for the Years 2015, 2023 &
2030

Table 83: China Recent Past, Current & Future Analysis for
Synthetic Biology by Application - Pharmaceuticals &
Diagnostics, Industrial, Food & Agriculture, Environmental and
Other Applications - Independent Analysis of Annual Revenues in
US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 84: China Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2021 and % CAGR

Table 85: China 15-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Revenues for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2023 &
2030

EUROPE
Synthetic Biology Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Europe for 2023 (E)
Table 86: Europe Recent Past, Current & Future Analysis for
Synthetic Biology by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2022 through 2030 and
% CAGR

Table 87: Europe Historic Review for Synthetic Biology by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2015 through 2021 and % CAGR

Table 88: Europe 15-Year Perspective for Synthetic Biology by
Geographic Region - Percentage Breakdown of Value Revenues for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2015, 2023 & 2030

Table 89: Europe Recent Past, Current & Future Analysis for
Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA,
Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic
Acids (XNA) and Chassis Organism - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 90: Europe Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2015 through 2021 and % CAGR

Table 91: Europe 15-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Revenues for
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism for the Years 2015, 2023 & 2030

Table 92: Europe Recent Past, Current & Future Analysis for
Synthetic Biology by Technology - Nucleotide Synthesis &
Sequencing, Genome Engineering, Microfluidics and Other
Technologies - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 93: Europe Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2021 and % CAGR

Table 94: Europe 15-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Revenues for
Nucleotide Synthesis & Sequencing, Genome Engineering,
Microfluidics and Other Technologies for the Years 2015, 2023 &
2030

Table 95: Europe Recent Past, Current & Future Analysis for
Synthetic Biology by Application - Pharmaceuticals &
Diagnostics, Industrial, Food & Agriculture, Environmental and
Other Applications - Independent Analysis of Annual Revenues in
US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 96: Europe Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2021 and % CAGR

Table 97: Europe 15-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Revenues for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2023 &
2030

FRANCE
Synthetic Biology Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in France for 2023 (E)
Table 98: France Recent Past, Current & Future Analysis for
Synthetic Biology by Tool - Oligonucleotides & Synthetic DNA,
Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic
Acids (XNA) and Chassis Organism - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 99: France Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2015 through 2021 and % CAGR

Table 100: France 15-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Revenues for
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism for the Years 2015, 2023 & 2030

Table 101: France Recent Past, Current & Future Analysis for
Synthetic Biology by Technology - Nucleotide Synthesis &
Sequencing, Genome Engineering, Microfluidics and Other
Technologies - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR

Table 102: France Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2021 and % CAGR

Table 103: France 15-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Revenues for
Nucleotide Synthesis & Sequencing, Genome Engineering,
Microfluidics and Other Technologies for the Years 2015, 2023 &
2030

Table 104: France Recent Past, Current & Future Analysis for
Synthetic Biology by Application - Pharmaceuticals &
Diagnostics, Industrial, Food & Agriculture, Environmental and

Please contact our Customer Support Center to get the complete Table of Contents

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.